🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hong Xiao

Fujian Medical University

ORCID: 0000-0002-9502-2063

Also affiliated with First Affiliated Hospital of Fujian Medical University

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic Autoantibodies”.

Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic Autoantibodies

UNC Libraries(2020)10.17615/edng-f542
N/A
0DataRank · unranked
20 citations

Adrian Schreiber, Hong Xiao, J. Charles Jennette, Peter Heeringa, Ronald J. Falk

The Role of Neutrophils in the Induction of Glomerulonephritis by Anti-Myeloperoxidase Antibodies

UNC Libraries(2020)10.17615/ya57-2b76
N/A
0DataRank · unranked
11 citations

Peiqi Hu, J. Charles Jennette, Ronald J. Falk, Peter Heeringa, Zhi Liu +3 more

Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice

UNC Libraries(2020)10.17615/ackw-0f73
N/A
0DataRank · unranked
0 citations

Ronald J. Falk, Peter Heeringa, Yasuaki Aratani, Hong Xiao, Nobuyo Maeda +4 more

The Medicaid expansion of the Affordable Care Act and participation of patients with Medicaid in cancer clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6505
N/A
0DataRank · unranked
3 citations

Hong Xiao, Riha Vaidya, Dawn L. Hershman, Joseph M. Unger

Survival outcomes by insurance status for patients with cancer ages 18-64 and 65 or older treated in clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.154
N/A
0DataRank · unranked
1 citations

Anna Moseley, Riha Vaidya, Hong Xiao, Michael LeBlanc, Dawn L. Hershman +1 more